Call for Abstracts - Postdoctoral Research Symposium
Sponsored by Emory’s Office of Postdoctoral Education, the 9th Annual Postdoctoral Research Symposium will take place on Thursday, May 19, 2016. This annual event is a time for postdocs across Emory to share and present their research to other postdocs and faculty. All Emory postdocs are encouraged to submit an abstract.
Poster categories are as follows:
- Biomedical Engineering
- Cancer and Oncological sciences
- Cell Biology and Biochemistry
- Clinical-Based and Translational Research
- Computational Biology and Bioinformatics
- Genetics and Molecular Biology
- Immunology and Microbiology
- Physical and Geological Sciences
- Public Health
Abstract Submission Deadline: March 1, 2016
CURE Childhood Cancer RFPCURE Childhood Cancer allocates approximately $2.5 million each year to research into cures and effective treatments with lower toxicity for childhood cancers. In granting funds, the highest priority is given to projects aimed at the 20% of children who are not surviving today's methods of treatments. With that in mind, proposals are sought for research involving the highest risk pediatric cancers, which CURE believes are generally considered to include:
- High risk ALL (presence of Philadelphia chromosome, hypodiploid DNA, no complete remission on day 28 post treatment or minimal residual disease (>1000 blasts/ml) on week 12, relapse ALL)
- Acute myeloid leukemia
- Neuroblastoma at stage 4, mycN amplified neuroblastoma
- Wilms tumor anaplastic stage IV (<50% survival), focus on late stage or relapse
- Metastatic sarcomas (bone and soft tissue, osteosarcoma)
- Brain tumors, high risk such as high grade or malignant astrocytomas, glioblastoma multiforme
CURE will also consider research related to other high-risk pediatric cancers. Proposals relating to these diseases should fall into one of the following categories:
- Innovative clinical therapy and transplantation;
- Mechanism of drug resistance and drug discovery;
- Study of novel tumor biomarkers for diagnostic, prognostic, therapeutic and vaccine development potential; and/or
- Genetics and/or Genomics as related to cancer development and treatment-resistance.
View Award Details
CURE will be placing highest priority on research proposals with an anticipated clinical or therapeutic application within the next 5 years. Collaborative projects are encouraged and will also be given priority. CURE remains very committed to supporting research related to survivorship and improved quality of life for pediatric cancer survivors.
Submission Process: Proposals should be submitted electronically (download cover sheet) to Kristin Connor at email@example.com.
Proposal Deadline: Friday, March 11, 2016 by close of business